GLP-1 pill race heats up as Wegovy tablet holds strong against Lilly rival

Novo Nordisk's (NYSE:NVO) Wegovy pill, the oral version of its blockbuster GLP-1 (glucagon-like peptide-1) weight-loss treatment, is tracking at roughly...